HSP90AA1 and lung cancer: Given that we know very little about the current crucial signaling pathways for canine lung tumor viability and considering we could target multiple signaling proteins with HSP90 inhibition, this prompted us to evaluate the pro-drug, STA-1474, in these canine lung cancer cell lines.